# Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

> **NCT03604315** · PHASE1 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 300 (estimated)

## Conditions studied

- Breast Carcinoma
- Fallopian Tube Carcinoma
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
- Solid Neoplasm

## Interventions

- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Computed Tomography
- **RADIATION:** Fludeoxyglucose F-18
- **RADIATION:** Fluorine F 18 Fluorthanatrace
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03604315
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-18
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604315, "Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03604315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*